Yearly Archives: 2018
News
MyTherapy Demonstrates Positive Trend Regarding Subjective Effects of Medication Adherence and Physical Activity in Patients with Lipid Metabolism Disorders
A study published by Charité - Universitätsmedizin Berlin, Germany, has demonstrated a significant improvement in medication adherence and physical activity in patients using a...
Articles
Point-of-Care Convenience and The Required Investments in Quality Assurance
Point-of-Care testing may be considered essential for patient care in emergencies where time is of the essence and delays in diagnosis and stabilisation mean...
News
Piedmont Athens Named to U.S. News & World Report’s Best Hospital List
Piedmont Athens Regional Medical Center has earned recognition from U.S. News & World Report on the publication’s 2018-19 Honor Roll of the Best Hospitals...
Press Releases
Medical, healthcare and MedTech innovations take centre stage at Asia’s leading exhibitions – MEDICAL FAIR ASIA & MEDICAL MANUFACTURING ASIA 2018
MEDICAL FAIR ASIA 2018 and MEDICAL MANUFACTURING ASIA 2018 was opened by Dr Koh Poh Koon, Senior Minister of State for Trade and Industry,...
Press Releases
The Pistoia Alliance Announces Number of Reactions in its Chemical Safety Library Service has Increased Four-Fold
The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, is announcing a number...
Press Releases
Novartis announces new data that show Entresto (sacubitril/valsartan) can be initiated early & safely in hospitalized patients after an acute heart failure episode
Data from the TRANSITION study presented at the European Society of Cardiology (ESC) Congress in Munich, Germany has shown that Entresto® (sacubitril/valsartan) can be...
Research Insight
Preliminary Data from Study Demonstrates 94% Accuracy in Detecting Aggressive Prostate Cancer
VolitionRx Limited announced preliminary data from a prospective, multi-centered Proof of Concept Study of 84 men into the utility of Volition's Nu.Qâ„¢ assays to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read